---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-135566"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2021-11-08T23:59:59+00:00"
generated_at: "2026-06-28T11:45:25.444509+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Semper Paratus closes $345M SPAC IPO; $351.9M placed in trust

## Summary
- Closed IPO of 34.5M units at $10.00 each, including full exercise of 4.5M-unit over-allotment.
- Gross IPO proceeds of $345M; private placement of 1.3M units to sponsor ($13M) and 150K units to Cantor ($1.5M).
- Trust account funded with $351.9M from IPO proceeds and private placements; 15-month deadline for business combination.
- Brad Stewart and Parizad Olver Parchi appointed to board; audit and compensation committees formed.

## SEC filing metadata
- accession: 0001104659-21-135566
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2021-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/tm2132195d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-135566
- JSON: https://secwatch.observer/filing/0001104659-21-135566.json
- Plain text: https://secwatch.observer/filing/0001104659-21-135566.txt

## Key facts
- Executive change
  Brad Stewart was appointed as Director at Tevogen Bio Holdings Inc..
  - Action: appointed
  - Role: Director
  source text: Effective November 3, 2021, Brad Stewart and Parizad Olver Parchi were appointed to the board of directors of the Company (the “ Board ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm
- Executive change
  Parizad Olver Parchi was appointed as Director at Tevogen Bio Holdings Inc..
  - Action: appointed
  - Role: Director
  source text: Effective November 3, 2021, Brad Stewart and Parizad Olver Parchi were appointed to the board of directors of the Company (the “ Board ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.